Quality of Life and Work Productivity Impairment among Psoriasis Patients: Findings from the National Psoriasis Foundation Survey Data 2003–2011

Objective To ascertain impairment in quality of life and work productivity among patients with psoriasis and psoriatic arthritis. Design From 2003 through 2011, the National Psoriasis Foundation collected survey data from patients with psoriasis and psoriatic arthritis via email and telephone correspondences. Setting Survey data were collected from psoriasis and psoriatic arthritis patients in the general community in the U.S. Main Outcome Measures Quality of life focusing on emotional impact (anger, frustration, helplessness, etc.) and physical impact (pain, pruritus, physical irritation, etc.); employment status. Patients The surveys were performed through random sampling of participants from a database of over 75,000 patients. Results From 2003 to 2011, 5,604 patients completed the surveys. Psoriasis and psoriatic arthritis affected overall emotional wellbeing in 88% of patients, and they interfered with enjoyment of life in 82%. Most patients reported experiencing anger (89%), frustration (89%), helplessness (87%), embarrassment (87%), and self-consciousness (89%). Many patients also actively concealed physical manifestations of their diseases (83%), and experienced pain (83%) and pruritus (93%) regularly. Of note, 12% of patients were unemployed, and 11% worked part-time. Among unemployed patients, 92% cited psoriasis and/or psoriatic arthritis as the sole reasons for not working. Among working patients, 49% missed work days regularly due to psoriasis. Compared to patients with mild psoriasis, patients with severe psoriasis have 1.8 times greater odds to be unemployed after adjusting for age and gender (Adjusted OR = 1.7, 95% CI 1.4–2.3). Conclusion Patients with psoriasis and psoriatic arthritis continue to experience significant impairment of quality of life and work productivity.

[1]  A. Kimball,et al.  The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis. , 2012, Journal of the American Academy of Dermatology.

[2]  E. Berardesca,et al.  Health-related quality of life in psoriasis: an analysis of Psocare project patients. , 2011, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia.

[3]  J. Szepietowski,et al.  A survey of disease severity, quality of life, and treatment patterns of biologically naive patients with psoriasis in central and eastern Europe. , 2010, Acta dermatovenerologica Croatica : ADC.

[4]  F. Aubin,et al.  What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  D. Symmons,et al.  Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti–tumor necrosis factor therapies , 2010, Arthritis care & research.

[6]  S. Segaert,et al.  Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[7]  S. Feldman,et al.  Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study , 2008, Health and quality of life outcomes.

[8]  K. Reich,et al.  The relationship between quality of life and skin clearance in moderate-to-severe psoriasis: lessons learnt from clinical trials with infliximab , 2008, Archives of Dermatological Research.

[9]  Elizabeth J Horn,et al.  Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. , 2007, Journal of the American Academy of Dermatology.

[10]  Elizabeth J Horn,et al.  Association of patient-reported psoriasis severity with income and employment. , 2007, Journal of the American Academy of Dermatology.

[11]  Elizabeth J Horn,et al.  National Psoriasis Foundation clinical consensus on disease severity. , 2007, Archives of dermatology.

[12]  S. Feldman,et al.  The negative impact of psoriasis on the workplace , 2006, The Journal of dermatological treatment.

[13]  S. Feldman,et al.  Decision points for the initiation of systemic treatment for psoriasis. , 2005, Journal of the American Academy of Dermatology.

[14]  David J Margolis,et al.  Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. , 2004, The journal of investigative dermatology. Symposium proceedings.

[15]  M. Gupta,et al.  Perceived deprivation of social touch in psoriasis is associated with greater psychologic morbidity: an index of the stigma experience in dermatologic disorders. , 1998, Cutis.

[16]  G. Schmid‐Ott,et al.  Dimensions of stigmatization in patients with psoriasis in a "Questionnaire on Experience with Skin Complaints'. , 1996, Dermatology.